Metabolic Syndrome: An Evolving Clinical Construct
Metabolic syndrome (MetS), a clustering of metabolic risk factors, identifies individuals at increased risk of diabetes and cardiovascular disease (CVD). Measurement of waist circumference, high-density lipoprotein-cholesterol, triglycerides, blood pressure and fasting blood glucose are easily obtained in the clinic. At any level of low-density lipoprotein-cholesterol, presence of MetS increases the risk of adverse CVD outcomes including both atherosclerotic CVD and atrial fibrillation. The MetS construct should focus the clinician on recommending behavioral lifestyle modification as this improves all of its components.
Source: Progress in Cardiovascular Diseases - Category: Cardiology Authors: Patricia Vassallo, Steven L. Driver, Neil J. Stone Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiovascular | Cholesterol | Diabetes | Endocrinology | Heart | Metabolic Syndrome